Related Experiment Video

Updated: Jun 12, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
12:55

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis

Published on: February 16, 2015

Cellular automata modeling of FASL-initiated apoptosis

Advait Apte1, Danail Bonchev, Stephen Fong

  • 1Department of Chemical and Life Science Engineering, Virginia Commonwealth University, 601 West Main Street, P.O. Box 843068, Richmond, Virginia 23284-3068, USA.

Chemistry & Biodiversity
|May 22, 2010
PubMed

Insights

This study models cancer cell death strategies. Maximizing apoptosis by inhibiting FLIP and IAP shows promise for cancer therapy, while protecting T-cells also offers a viable approach.

Area of Science:

  • Computational Biology
  • Cancer Research
  • Immunology

Background:

  • FASL-induced apoptosis is crucial in cancer and immunity.
  • Modulating apoptosis pathways offers therapeutic potential.
  • FLIP and IAP are key inhibitors of apoptosis.

Purpose of the Study:

  • To model two strategies for fighting cancer by modulating FASL-induced apoptosis.
  • To predict the efficacy of inhibiting apoptosis regulators (FLIP, IAP) in cancer cells.
  • To assess the potential of overexpressing apoptosis inhibitors to protect T-cells.

Main Methods:

  • Utilized 2D-cellular automata modeling.
  • Simulated the effects of siRNA and SMAC proteins on apoptosis.
  • Modeled the overexpression of FLIP and IAP inhibitors.

Main Results:

  • Joint suppression of FLIP and IAP inhibitors maximizes cancer cell apoptosis.
  • Overexpression of FLIP and IAP shows synergy in protecting T-cells.
  • Identified a feedback loop accelerating apoptosis without significantly altering DNA-decomposing protein levels.
  • Characterized cell type conversion as a compensatory mechanism for FASL pathway damage.

Conclusions:

  • Dual suppression or overexpression of apoptosis inhibitors presents a promising strategy against cancer.
  • Modeling provides insights into optimizing cancer therapies by targeting apoptosis pathways.
  • Understanding these pathways can aid in developing novel treatments for cancer and immune system protection.

More Related Videos

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation08:47

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation

Published on: March 5, 2018

In Vivo Biosensor Tracks Non-apoptotic Caspase Activity in Drosophila13:21

In Vivo Biosensor Tracks Non-apoptotic Caspase Activity in Drosophila

Published on: November 27, 2016

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...